BUCHANAN INGERSOLL & ROONEY PC for BROWN'S COMPOUNDING
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Insurance INS
Tricare reimbursement; basic insurance policies affecting the industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL LE | — |
| JON W PLEBANI | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK New | — |
| JAMES C WILTRAUT | — |
Health Issues HCR
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; Drug Quality and Security Act PL113-54
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL LE | — |
| JON W PLEBANI | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK New | — |
| JAMES C WILTRAUT | — |
Veterans VET
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL LE | — |
| JON W PLEBANI | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK New | — |
| JAMES C WILTRAUT | — |
Budget/Appropriations BUD
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; HR 83; Consolidated and Further Continuing Appropriations Act, 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL LE | — |
| JON W PLEBANI | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK New | — |
| JAMES C WILTRAUT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.